rs56046122

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_138477.4(CDAN1):​c.3450+11C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0213 in 1,614,006 control chromosomes in the GnomAD database, including 1,547 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.060 ( 631 hom., cov: 32)
Exomes 𝑓: 0.017 ( 916 hom. )

Consequence

CDAN1
NM_138477.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -2.02

Publications

4 publications found
Variant links:
Genes affected
CDAN1 (HGNC:1713): (codanin 1) This gene encodes a protein that appears to play a role in nuclear envelope integrity, possibly related to microtubule attachments. Mutations in this gene cause congenital dyserythropoietic anemia type I, a disease resulting in morphological and functional abnormalities of erythropoiesis. [provided by RefSeq, Jul 2009]
CDAN1 Gene-Disease associations (from GenCC):
  • anemia, congenital dyserythropoietic, type 1a
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • congenital dyserythropoietic anemia type 1
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • congenital dyserythropoietic anemia
    Inheritance: AR Classification: LIMITED Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BP6
Variant 15-42725478-G-A is Benign according to our data. Variant chr15-42725478-G-A is described in ClinVar as Benign. ClinVar VariationId is 262375.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.173 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDAN1NM_138477.4 linkc.3450+11C>T intron_variant Intron 26 of 27 ENST00000356231.4 NP_612486.2 Q8IWY9-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDAN1ENST00000356231.4 linkc.3450+11C>T intron_variant Intron 26 of 27 1 NM_138477.4 ENSP00000348564.3 Q8IWY9-2

Frequencies

GnomAD3 genomes
AF:
0.0603
AC:
9171
AN:
152088
Hom.:
629
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.176
Gnomad AMI
AF:
0.0395
Gnomad AMR
AF:
0.0240
Gnomad ASJ
AF:
0.0340
Gnomad EAS
AF:
0.0591
Gnomad SAS
AF:
0.0427
Gnomad FIN
AF:
0.00396
Gnomad MID
AF:
0.0253
Gnomad NFE
AF:
0.0103
Gnomad OTH
AF:
0.0450
GnomAD2 exomes
AF:
0.0298
AC:
7480
AN:
251044
AF XY:
0.0282
show subpopulations
Gnomad AFR exome
AF:
0.177
Gnomad AMR exome
AF:
0.0121
Gnomad ASJ exome
AF:
0.0335
Gnomad EAS exome
AF:
0.0661
Gnomad FIN exome
AF:
0.00333
Gnomad NFE exome
AF:
0.0103
Gnomad OTH exome
AF:
0.0214
GnomAD4 exome
AF:
0.0173
AC:
25248
AN:
1461800
Hom.:
916
Cov.:
32
AF XY:
0.0178
AC XY:
12928
AN XY:
727218
show subpopulations
African (AFR)
AF:
0.188
AC:
6292
AN:
33474
American (AMR)
AF:
0.0143
AC:
638
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0367
AC:
960
AN:
26136
East Asian (EAS)
AF:
0.0517
AC:
2052
AN:
39700
South Asian (SAS)
AF:
0.0444
AC:
3828
AN:
86256
European-Finnish (FIN)
AF:
0.00352
AC:
188
AN:
53396
Middle Eastern (MID)
AF:
0.0229
AC:
132
AN:
5768
European-Non Finnish (NFE)
AF:
0.00864
AC:
9602
AN:
1111956
Other (OTH)
AF:
0.0258
AC:
1556
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
1418
2835
4253
5670
7088
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
514
1028
1542
2056
2570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0604
AC:
9192
AN:
152206
Hom.:
631
Cov.:
32
AF XY:
0.0587
AC XY:
4367
AN XY:
74430
show subpopulations
African (AFR)
AF:
0.176
AC:
7311
AN:
41518
American (AMR)
AF:
0.0240
AC:
367
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.0340
AC:
118
AN:
3470
East Asian (EAS)
AF:
0.0592
AC:
306
AN:
5170
South Asian (SAS)
AF:
0.0429
AC:
207
AN:
4826
European-Finnish (FIN)
AF:
0.00396
AC:
42
AN:
10614
Middle Eastern (MID)
AF:
0.0306
AC:
9
AN:
294
European-Non Finnish (NFE)
AF:
0.0103
AC:
702
AN:
68004
Other (OTH)
AF:
0.0445
AC:
94
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
392
784
1177
1569
1961
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
98
196
294
392
490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0343
Hom.:
488
Bravo
AF:
0.0662
Asia WGS
AF:
0.0510
AC:
178
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

May 11, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Congenital dyserythropoietic anemia, type I Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Anemia, congenital dyserythropoietic, type 1a Benign:1
Nov 08, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.96
CADD
Benign
2.6
DANN
Benign
0.46
PhyloP100
-2.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs56046122; hg19: chr15-43017676; API